CBX8
Chromobox protein homolog 8
Also known as: CBX8_HUMAN, HPC3, PC3, RC1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HC52
- Gene
- CBX8
- Ensembl
- ENSG00000141570
- Chromosome
- 17
- Canonical length
- 389 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables methylated histone binding activity. Involved in negative regulation of transcription by RNA polymerase II. Located in chromatin and nucleoplasm. Part of PRC1 complex. Biomarker of esophagus squamous cell carcinoma and glioblastoma. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
389 residues, UniProt reviewed canonical sequence.
>Q9HC52|CBX8
1 MELSAVGERV FAAEALLKRR IRKGRMEYLV KWKGWSQKYS TWEPEENILD ARLLAAFEER
61 EREMELYGPK KRGPKPKTFL LKAQAKAKAK TYEFRSDSAR GIRIPYPGRS PQDLASTSRA
121 REGLRNMGLS PPASSTSTSS TCRAEAPRDR DRDRDRDRER DRERERERER ERERERERER
181 GTSRVDDKPS SPGDSSKKRG PKPRKELPDP SQRPLGEPSA GLGEYLKGRK LDDTPSGAGK
241 FPAGHSVIQL ARRQDSDLVQ CGVTSPSSAE ATGKLAVDTF PARVIKHRAA FLEAKGQGAL
301 DPNGTRVRHG SGPPSSGGGL YRDMGAQGGR PSLIARIPVA RILGDPEEES WSPSLTNLEK
361 VVVTDVTSNF LTVTIKESNT DQGFFKEKRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CBX8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 10 nTPM
Expression across tissuesHPA
Tissue
- testis: 10 nTPM
- epididymis: 10 nTPM
- pituitary gland: 7 nTPM
- parathyroid gland: 6.2 nTPM
- liver: 5.3 nTPM
- fallopian tube: 5 nTPM
Single-cell type
- fallopian tube ciliated cells: 20 nCPM
- differentiating spermatogonia: 17 nCPM
- epididymal principal cells: 16 nCPM
- endometrial ciliated cells: 16 nCPM
- epididymal efferent duct ciliated cells: 12 nCPM
- cholangiocytes: 11 nCPM
Immune cell
- eosinophil: 15 nTPM
- non-classical monocyte: 7.4 nTPM
- intermediate monocyte: 6.8 nTPM
- neutrophil: 6.3 nTPM
- myeloid DC: 5.7 nTPM
- classical monocyte: 5 nTPM
Brain region
- white matter: 6.6 nTPM
- thalamus: 5.8 nTPM
- pons: 5.3 nTPM
- medulla oblongata: 5.1 nTPM
- hypothalamus: 5 nTPM
- amygdala: 4.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 0.94
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to hydrogen peroxide
- negative regulation of transcription by RNA polymerase II
- positive regulation of cell population proliferation
- positive regulation of collagen biosynthetic process
- positive regulation of DNA repair
Molecular functions
- chromatin binding
- histone H3K27me3 reader activity
- single-stranded RNA binding
- ubiquitin-protein transferase activator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CBX8 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CBX8 as an antibody target. Whether an autoantibody or antibody against CBX8 could matter depends on whether native CBX8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CBX8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CBX8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...